| |
median (min, max)
|
|
Age (years)
|
6.63 (2.18–17.48)
|
7.70 (2.02–16.68)
|
0.60
|
|
Status, Lansky or Karnofsky score (%)
|
100 (40–100)
|
100 (40–100)
|
0.86
|
|
Platelet count
|
189.5 (11–660)
|
201.5 (24–609)
|
0.63
|
|
Number of previous LP
|
2 (0–16)
|
2 (0–16)
|
0.82
|
| |
N (%)
|
|
Male
|
38 (61.3)
|
37 (59.7)
|
0.85
|
|
Previous LP
|
55 (88.7)
|
57 (91.9)
|
0.54
|
|
Description of the LP
|
(n, %)
|
|
Premedication
|
21 (33.9)
|
15 (24.2)
|
0.24
|
|
EMLA®
|
61 (98.4)
|
61 (98.4)
|
1
|
|
Entonox
|
57 (91.9)
|
60 (96.8)
|
0.24
|
|
Purpose of LP
| | |
0.3
|
|
Diagnosis*
|
7 (11.3)
|
7 (11.3)
| |
|
Disease follow-up
|
10 (16.1)
|
4 (6.5)
| |
|
Treatment injection
|
45 (72.6)
|
51 (82.3)
| |
| |
Median (min-max)
|
|
LP duration (minutes)
|
4 (1–33)
|
4 (2–19)
|
0.52§
|
|
Number of attempts
|
1 (1–5)
|
1 (1–4)
|
0.98§
|
|
Amount of CSF** withdrawn (drops)
|
20 (10–34)
|
20 (20–40)
|
0.3§
|
|
Number of attending persons
|
4(2–7)
|
4 (2–5)
|
0.5§
|
|
LP performed in sitting position (first attempt), (n, %)
|
62 (100)
|
62 (100)
| |
